We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Karl Storz Acquires British AI Specialist Innersight Labs

By HospiMedica International staff writers
Posted on 11 Jan 2024
Print article
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)

KARL STORZ (Tuttlingen, Germany), a family-owned MedTech company, has acquired Innersight Labs Ltd. (ISL, London, UK), an innovative software manufacturer for an undisclosed amount. Apart from state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ continues its expansion into innovative software solutions. The company’s wide customer base, which includes top-class physicians across the world, can now enjoy access to 3D models created from medical scans, making surgery much easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will significantly enhance the KARL STORZ portfolio.

ISL has developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels the received scans according to different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications. In comparison to competing products, ISL's AI-based algorithm can significantly reduce manual effort, lowering cost per model and time to deployment.

As part of the globally active KARL STORZ Group, ISL will now focus on commercial scaling and joint technology development. The ISL acquisition adds an AI product to the existing KARL STORZ portfolio marking the next step in its efforts to integrate AI into laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ aims to incorporate the extensive possibilities offered by AI into the development of cutting-edge medical technology at an early stage, allowing it to offer the best instruments for patients with the highest safety standards in the market.

Related Links:
KARL STORZ
Innersight Labs Ltd.

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Washer Disinfector
Tiva 2
New
Bariatric Flip Seat Scale
Detecto 6868

Print article

Channels

Critical Care

view channel
Image: The study revealed how stress-related alterations in blood flow and blood vessel function are closely associated with heart disease (Photo courtesy of 123RF)

New Cardiovascular Risk Score Uses Stress Test to Predict Heart Disease More Accurately

A recent study has paved the way for the development of a new cardiovascular reactivity risk score, which could improve the ability to identify high-risk patients under stress and accelerate their diagnosis... Read more

Surgical Techniques

view channel
Image: Application of Pericelle to the porcine model of femoral arterio-venous fistula (Photo courtesy of Bioactive Materials, DOI:10.1016/j.bioactmat.2024.10.005)

Nanotechnology-Based Drug Delivery System Could Help Dialysis and Heart Patients Avoid Repeat Surgeries

Revascularization procedures are essential for treating cardiovascular disease by restoring the necessary blood flow. For instance, a surgeon may transfer a vein from the leg to the heart to help patients... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.